Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million Americans aged 40 and older currently living with AMD. Most cases are the ...

FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

The leading cause of vision loss has had some treatment breakthroughs in the past five years. Find out the different techniques that scientists are hoping are becoming the new standard of care ...

A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...

It would be devastating to lose your eyesight to macular degeneration. Age-related macular degeneration (AMD) is a progressive eye disease that affects those over the age of 50. There is ...

Scientists have developed a new eyedrop that can ferry protective compounds all the way to the retina, paving the way for a less-invasive injection-free method of managing sight-stealing diseases such ...

Age-related macular degeneration (AMD) remains a leading cause of vision loss globally, with significant advancements in treatment options for both dry and wet AMD. As highlighted by Huang and ...

GENEVA--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire LumiThera, Inc., a leader in light-based ...

Age-related macular degeneration (AMD) causes significant vision loss in seniors who have it. And there are many of them.